European RWE & Market Access
Summit 2027

Name: European RWE & Market Access Summit 2027
Start: 2027-10-21T08:00:00+00:00
End: 2027-10-22T17:00:00+00:00
Location: TBA

Loading . . .

October 2027

Agenda under production

Register Now !

00Days
00Hours
00Minutes

The JCA & PICO Strategy

Wlcus

European RWE & Market Access Summit 2027,
October 21-22.

The 3rd Annual European RWE & Market Access Summit 2027 is the pharmaceutical industry’s definitive Implementation War Room, designed to navigate the high-stakes transition into the New European HTA Era. As Joint Clinical Assessments (JCA) become mandatory for oncology and ATMPs, the mission of this summit is to provide Market Access, HEOR, and RWE leaders with a technical roadmap for the critical 100-day submission window.

This specialized 2026 edition moves beyond theory, delivering actionable insights into PICO strategy (Population, Intervention, Comparator, and Outcome), bias mitigation, and the operationalization of DARWIN EU 2.0 for regulatory-grade evidence generation. By attending, cross-functional teams will master national HTA readiness, aligning global evidence planning with EMA technical requirements and multi-state payer priorities. From Evidence-to-Access frameworks to solving PICO anxiety, this summit is the essential briefing for ensuring your 2026–2028 pipeline achieves successful reimbursement and long-term market sustainability across Europe.

2027 Strategic Focus

Why This Summit is the Industry’s Definitive “Don’t-Miss” Briefing

JCA Submission Mastery

Navigate the high-stakes transition into mandatory Joint Clinical Assessments with a tactical roadmap for oncology and ATMP dossiers. Gain the “how-to” on meeting aggressive timelines and ensuring your evidence package is fully compliant with the new 100-day submission window.

PICO Scoping & Strategy

Eliminate “PICO anxiety” by learning predictive frameworks to anticipate the Population, Intervention, Comparator, and Outcome requirements of diverse Member States. Master the art of bias mitigation and statistical alignment to prevent costly delays in your submission process.

DARWIN EU 2.0 Operations

Get a direct technical briefing on the EMA’s DARWIN EU network and its transformative role in multi-state data interoperability. Learn to generate “regulatory-grade” evidence that meets the highest standards of data quality and scientific integrity for 2026–2028.

National HTA Alignment

Solve the challenge of national divergence by aligning global RWE strategies with the specific priorities of local payers and HTA bodies. Transition from broad data collection to precision evidence that addresses country-specific pricing and reimbursement hurdles.

AI-Driven Evidence Synthesis

Explore the commercial integration of AI and machine learning to streamline RWE operations and automate complex data synthesis. Discover how to reduce the “data-to-submission” lifecycle, providing your cross-functional teams a competitive edge in rapid-response environments.

Payer & Regulator Networking

Break down organizational silos by engaging in closed-door discussions with the key architects of the European HTA landscape. Build the high-level networks necessary to influence policy, understand payer sentiment, and secure long-term market sustainability for your pipeline.